Empagliflozin Increases Cardiac Energy Production in Diabetes

Subodh Verma, Sonia Rawat, Kim L. Ho, +10

JACC Basic to Translational Science

Cardiac Insulin-Resistance and Decreased Mitochondrial Energy Production Precede the Development of Systolic Heart Failure After Pressure-Overload Hypertrophy

Liyan Zhang, Jagdip S. Jaswal, John R. Ussher, +4

Circulation Heart Failure

Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling

Osama Abo Alrob, Sowndramalingam Sankaralingam, Cary Ma, +11

Cardiovascular Research

Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency

Kim L. Ho, Liyan Zhang, Cory S. Wagg, +9

Cardiovascular Research

Angiotensin 1–7 Ameliorates Diabetic Cardiomyopathy and Diastolic Dysfunction in <i>db/db</i> Mice by Reducing Lipotoxicity and Inflammation

Jun Mori, Vaibhav B. Patel, Osama Abo Alrob, +7

Circulation Heart Failure

Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury

John R. Ussher, Wei Wang, Manoj Gandhi, +9

Cardiovascular Research

Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure

Golam M. Uddin, Liyan Zhang, Saumya Shah, +14

Cardiovascular Diabetology

Cardiac MuscleHeart FailureCardiac Bcaa AccumulationCardiac Insulin ResistanceMetabolic Remodeling +17

Agonist-Induced Hypertrophy and Diastolic Dysfunction Are Associated With Selective Reduction in Glucose Oxidation

Jun Mori, Ratnadeep Basu, Brent A. McLean, +7

Circulation Heart Failure

HypertensionHeart FailureConcentric HypertrophyCardiovascular PharmacologyCardiovascular Function +26

ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4

Jun Mori, Osama Abo Alrob, Cory S. Wagg, +3

American Journal of Physiology-Heart and Circulatory Physiology

Heart FailureCardiovascular PharmacologyAng IiMetabolic RemodelingCardiovascular Function +17

Fatty Acid Translocase/CD36 Deficiency Does Not Energetically or Functionally Compromise Hearts Before or After Ischemia

Michael Kuang, Maria Febbraio, Cory S. Wagg, +2

Circulation